Non-modifiable risk factors include advancing age (particularly over 60 years), Caucasian ethnicity, family history of AMD, and genetic variants in complement pathway genes
Common experiences: Occasional mild GI symptoms, stable energy, reduced food noise, feeling normal on medication
Tirzepatide Here at Integrative Medicine, Laser, and Aesthetics, we help people decide between semaglutides and tirzepatides for their weight loss journey
But women, who have higher rates of GLP-1 treatment use than men, may at be at heightened risk of bone weakening during menopause, when bone loss naturally accelerates
Common Decision Patterns Profile A: Financial Capacity + Health Improvements Recommended path: Chronic treatment with dose reduction to maintenance level Rationale: You have means to sustain treatment and clear medical benefits that would be lost with discontinuation
Potential Benefits: Enhanced Skin Health and Appearance: Each component contributes to healthier, more resilient skin with reduced signs of aging